| A multiomics approach to heterogeneity in Alzheimer’s disease: focused review and roadmap AP Badhwar, GP McFall, S Sapkota, SE Black, H Chertkow, S Duchesne, ... Brain 143 (5), 1315-1331, 2020 | 148 | 2020 |
| Profiling novel metabolic biomarkers for Parkinson's disease using in‐depth metabolomic analysis W Han, S Sapkota, R Camicioli, RA Dixon, L Li Movement Disorders 32 (12), 1720-1728, 2017 | 99 | 2017 |
| Metabolomics analyses of saliva detect novel biomarkers of Alzheimer’s disease T Huan, T Tran, J Zheng, S Sapkota, SW MacDonald, R Camicioli, ... Journal of Alzheimer's Disease 65 (4), 1401-1416, 2018 | 79 | 2018 |
| Alzheimer’s biomarkers from multiple modalities selectively discriminate clinical status: relative importance of salivary metabolomics panels, genetic, lifestyle, cognitive … S Sapkota, T Huan, T Tran, J Zheng, R Camicioli, L Li, RA Dixon Frontiers in Aging Neuroscience 10, 296, 2018 | 43 | 2018 |
| Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and … S Sapkota, L Bäckman, RA Dixon Neurobiology of Aging 52, 81-89, 2017 | 37 | 2017 |
| Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E S Sapkota, D Vergote, D Westaway, J Jhamandas, RA Dixon Neurobiology of Aging 36 (1), 249-256, 2015 | 36* | 2015 |
| Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease S Sapkota, M Gee, J Sabino, D Emery, R Camicioli Movement Disorders 29 (3), 368-374, 2014 | 32 | 2014 |
| Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented … GP McFall, S Sapkota, KL McDermott, RA Dixon Neurobiology of Aging 42, 91-100, 2016 | 27 | 2016 |
| A network of genetic effects on non-demented cognitive aging: Alzheimer’s genetic risk (CLU+ CR1+ PICALM) intensifies cognitive aging genetic risk (COMT+ BDNF) selectively for … S Sapkota, RA Dixon Journal of Alzheimer's Disease 62 (2), 887-900, 2018 | 17 | 2018 |
| Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non‐demented older adults S Sapkota, SA Wiebe, BJ Small, RA Dixon International journal of geriatric psychiatry 31 (5), 502-509, 2016 | 17 | 2016 |
| Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women S Sapkota, J Ramirez, DT Stuss, M Masellis, SE Black Alzheimer's research & therapy 10, 1-13, 2018 | 14 | 2018 |
| Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume S Sapkota, K Erickson, D Harvey, SE Tomaszewski‐Farias, JM Olichney, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 9 | 2022 |
| Brain atrophy trajectories predict differential functional performance in Alzheimer's disease: Moderations with apolipoprotein E and sex S Sapkota, J Ramirez, V Yhap, M Masellis, SE Black, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 9 | 2021 |
| P3‐090: Metabolomics analyses of salivary samples discriminate normal aging, mild cognitive impairment, and Alzheimer's disease groups and produce biomarkers predictive of … S Sapkota, T Tran, T Huan, K Lechelt, S MacDonald, R Camicioli, L Li, ... Alzheimer's & Dementia 11 (7S_Part_14), P654-P654, 2015 | 6 | 2015 |
| A multimodal risk network predicts executive function trajectories in non-demented aging S Sapkota, GP McFall, M Masellis, RA Dixon Frontiers in Aging Neuroscience 13, 621023, 2021 | 5 | 2021 |
| Differential cognitive decline in alzheimer’s disease is predicted by changes in ventricular size but moderated by apolipoprotein e and pulse pressure S Sapkota, GP McFall, M Masellis, RA Dixon, SE Black Journal of Alzheimer's Disease 85 (2), 545-560, 2022 | 4 | 2022 |
| Vascular Risk Predicts Plasma Amyloid β 42/40 Through Cerebral Amyloid Burden in Apolipoprotein E ε4 Carriers S Sapkota, K Erickson, E Fletcher, SE Tomaszewski Farias, LW Jin, ... Stroke 54 (5), 1227-1235, 2023 | 2 | 2023 |
| Trajectories and modifiers of executive function: Normal aging to neurodegenerative disease GP McFall, S Sapkota, S Thibeau, RA Dixon Executive Function, 263-277, 2017 | 2 | 2017 |
| [P2–353]: TOWARD DISCOVERY OF MULTI‐OMICS BIOTYPES OF ALZHEIMER's DISEASE: A FOCUSED REVIEW AND PROPOSED ROADMAP AP Badhwar, GP McFall, S Sapkota, H Chertkow, RA Dixon, P Bellec Alzheimer's & Dementia 13 (7S_Part_15), P757-P757, 2017 | 1 | 2017 |
| Synergistic Associations of Genetic, Demographic, Health, and Lifestyle Risk Factors on Neurocognitive Performance and Change in Aging S Sapkota | 1 | 2016 |
